Outcomes of Uniportal Video-Assisted Thoracoscopic Surgery in the Management of Lobectomy and Segmentectomy for Lung Cancer: A Systematic Review and Meta-Analysis of Propensity Score-Matched Cohorts.

I Wayan Sudarma, Putu Febry Krisna Pertiwi, Ketut Putu Yasa, I Komang Adhi Parama Harta
Author Information
  1. I Wayan Sudarma: Cardiothoracic and Vascular Surgery Division, Department of Surgery, Faculty of Medicine, Udayana University, Bali, Indonesia. ORCID
  2. Putu Febry Krisna Pertiwi: Faculty of Medicine, Udayana University, Bali, Indonesia. ORCID
  3. Ketut Putu Yasa: Cardiothoracic and Vascular Surgery Division, Department of Surgery, Faculty of Medicine, Udayana University, Bali, Indonesia. ORCID
  4. I Komang Adhi Parama Harta: Cardiothoracic and Vascular Surgery Division, Department of Surgery, Faculty of Medicine, Udayana University, Bali, Indonesia. ORCID

Abstract

PURPOSE: Uniportal video-assisted thoracoscopic surgery (UVATS) has been increasingly adopted for lung cancer management. This study aims to compare the perioperative and oncological outcomes of UVATS versus multiportal VATS (MVATS).
METHODS: A comprehensive search was conducted on electronic databases. Perioperative outcomes evaluated were postoperative complications, conversion to open thoracotomy, and visual analog scale (VAS) scores on postoperative days 1 (POD1) and 3 (POD3). The oncological outcomes assessed were total lymph nodes retrieved. Individual patient time-to-event data were estimated from published Kaplan-Meier curves.
RESULTS: The analysis demonstrated that UVATS was associated with significantly lower postoperative complications (relative risk [RR]: 0.76; 95% confidence interval [CI]: 1.64-0.91; p = 0.002), lower VAS scores on POD1(MD: -0.44; 95% CI: -0.70, -0.17; p = 0.001) and POD3 (MD: 0.76; 95% CI: -1.17, -0.36; p <0.001) compared to MVATS. Although UVATS had a lower conversion rate, this difference was not statistically significant (RR: 0.63; 95% CI: 0.33-1.18; p = 0.15). MVATS retrieved a higher number of lymph nodes, but this difference was also not statistically significant (MD: 0.6; 95% CI: -1.39, 0.12, p = 0.1). The overall survival probability at 96 months was slightly higher in the MVATS group (82.49%) compared to the UVATS group (75.89%), with a p-value of 0.5. Disease-free survival was comparable between the groups (75.43% UVATS and 74.74% MVATS, p = 0.59).
CONCLUSION: UVATS demonstrated favorable perioperative outcomes and comparable oncological efficacy to MVATS in the management of lobectomy and segmentectomy for lung cancer.

Keywords

References

  1. J BUON. 2021 Jul-Aug;26(4):1453-1459 [PMID: 34565004]
  2. Eur J Cardiothorac Surg. 2006 Nov;30(5):787-92 [PMID: 16971134]
  3. J Thorac Dis. 2016 Oct;8(10):2872-2878 [PMID: 27867563]
  4. Medicine (Baltimore). 2020 Oct 16;99(42):e22719 [PMID: 33080728]
  5. Korean J Thorac Cardiovasc Surg. 2017 Oct;50(5):339-345 [PMID: 29124025]
  6. Chin Med J (Engl). 2015 Oct 20;128(20):2731-5 [PMID: 26481738]
  7. J Thorac Cardiovasc Surg. 2012 Mar;143(3):745-7 [PMID: 21868042]
  8. J Formos Med Assoc. 2023 Sep;122(9):947-954 [PMID: 37169655]
  9. World J Surg Oncol. 2022 Jun 4;20(1):181 [PMID: 35659244]
  10. Eur J Cardiothorac Surg. 2016 Jan;49 Suppl 1:i48-53 [PMID: 26464451]
  11. J Thorac Dis. 2017 Oct;9(10):3866-3874 [PMID: 29268396]
  12. Oncol Lett. 2019 Aug;18(2):1311-1317 [PMID: 31423191]
  13. J Natl Compr Canc Netw. 2019 Dec;17(12):1464-1472 [PMID: 31805526]
  14. J Vis Surg. 2017 Nov 07;3:157 [PMID: 29302433]
  15. J Thorac Dis. 2023 Aug 31;15(8):4216-4228 [PMID: 37691649]
  16. Sci Rep. 2024 Mar 4;14(1):5316 [PMID: 38438473]
  17. BMC Med Res Methodol. 2012 Feb 01;12:9 [PMID: 22297116]
  18. Eur J Cardiothorac Surg. 2021 Apr 13;59(3):650-657 [PMID: 33230524]
  19. BMJ. 2021 Mar 29;372:n160 [PMID: 33781993]
  20. Semin Radiat Oncol. 2003 Jul;13(3):176-81 [PMID: 12903007]
  21. Mayo Clin Proc. 2019 Aug;94(8):1623-1640 [PMID: 31378236]
  22. J Thorac Oncol. 2016 Jan;11(1):39-51 [PMID: 26762738]
  23. Semin Thorac Cardiovasc Surg. 2020 Spring;32(1):145-151 [PMID: 31150825]
  24. Interact Cardiovasc Thorac Surg. 2011 Mar;12(3):514-5 [PMID: 21131682]
  25. J Thorac Dis. 2022 Sep;14(9):3154-3166 [PMID: 36245574]

MeSH Term

Humans
Thoracic Surgery, Video-Assisted
Pneumonectomy
Lung Neoplasms
Treatment Outcome
Risk Factors
Male
Female
Postoperative Complications
Middle Aged
Propensity Score
Time Factors
Aged
Lymph Node Excision

Word Cloud

Created with Highcharts 10.0.00UVATSMVATSp95%=outcomes-0CI:surgerylungoncologicalpostoperative1lowerMD:survivalUniportalvideo-assistedthoracoscopiccancermanagementperioperativecomplicationsconversionVASscoresPOD1POD3lymphnodesretrievedanalysisdemonstrated7617001-1compareddifferencestatisticallysignificanthighergroup75comparablePURPOSE:increasinglyadoptedstudyaimscompareversusmultiportalVATSMETHODS:comprehensivesearchconductedelectronicdatabasesPerioperativeevaluatedopenthoracotomyvisualanalogscaledays3assessedtotalIndividualpatienttime-to-eventdataestimatedpublishedKaplan-MeiercurvesRESULTS:associatedsignificantlyrelativerisk[RR]:confidenceinterval[CI]:64-091002447036<0AlthoughrateRR:6333-11815numberalso63912overallprobability96monthsslightly8249%89%p-value5Disease-freegroups43%7474%59CONCLUSION:favorableefficacylobectomysegmentectomyOutcomesVideo-AssistedThoracoscopicSurgeryManagementLobectomySegmentectomyLungCancer:SystematicReviewMeta-AnalysisPropensityScore-MatchedCohortsneoplasmthoracic

Similar Articles

Cited By